Putting the patient first in rare disease trials eBook

Putting the patient first in rare disease respiratory trial

Designing studies for rare respiratory diseases such as IPF, CF, NCFB and PAH presents researchers with a unique set of challenges.

Success in rare respiratory studies hinges on a mix of patient-centric designs and specialized solutions, demanding a precise collaboration among patients, health care providers and advocacy groups, among others.

Our clinical research team has tapped into their deep respiratory expertise and experience conducting over 175 respiratory trials in just the past five years to share best practices and pragmatic solutions proven to support success in rare respiratory research.